February 5, 2009 - The National Policy Board of US Oncology, which supports one of the nation's largest cancer treatment and research networks representing approximately 1,200 oncologists nationwide, this week adopted its Principles for Reforming Cancer Care, designed to guide the organization's national legislative agenda as it works with physicians, manufacturers and payers to enhance patient access to advanced cancer care in the community setting.

"These reform principles are intended to provide a clear understanding at the onset of the 2009 legislative session of the philosophies that will guide our legislative and administrative policy agenda on behalf of our physician network and the patients we serve," said Edward R. George, M.D., chairman of the US Oncology National Policy Board. "With a variety of complex healthcare legislation proposals and policy reform ideas introduced with ever-increasing speed this year, it is important to always remain clear on our steadfast goals in support of America's cancer patients, and this document serves to keep these objectives in the forefront in all legislative discussions."

The principles state that:

1. All cancer patients should:

- Have access to integrated, outpatient care in the community where they live

- Receive high-quality, evidence-based, comprehensive care

- Have access to clinical trials studying the latest promising therapies

- Be assured the drugs administered to them are genuine and
unadulterated

- Obtain needed care without the threat of severe financial hardship and without regard to ability to pay

2. All patients with incurable cancers or late-stage disease should:

- Receive clear communication about their prognosis

- Have access to high-quality, evidence-based palliative care,
supportive care and end-of-life planning as appropriate to meet their individual physical, mental, social and spiritual needs

3. Payment policies should incentivize physicians to provide high-quality, evidence-based care that reflects clinical excellence and value.

4. Payers should incentivize the use of healthcare information technology to empower efficient, high quality cancer care.

For more information: www.usoncology.com

Related Content

News | Interventional Radiology

Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Time July 03, 2019
arrow
Technology | Focused Ultrasound Therapy

Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).

Time December 21, 2018
arrow
Videos | Radiation Oncology

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation ...

Time November 06, 2018
arrow
News | Radiation Dose Management

AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

Time September 24, 2018
arrow
News | Radiation Oncology

World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...

Time February 01, 2018
arrow
News | Oncology Related Products

December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...

Time December 19, 2016
arrow
News | Clinical Decision Support

October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use ...

Time October 27, 2016
arrow
News | Ultrasound Imaging

September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...

Time September 12, 2016
arrow
Feature | Cardio-oncology | Dave Fornell

Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat ...

Time May 13, 2016
arrow
News | Oncology Related Products

May 6, 2016 — After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy ...

Time May 06, 2016
arrow
Subscribe Now